Cyclin D1 expression of different histological grades in oral squamous cell carcinoma patients from northern India

  • Manzoor Ahmad Gatoo Aligarh Muslim University, Jawaharlal Nehru Medical College, Department of Medical Biochemistry, Aligarh, India
  • Ayaz Mahmood Dar Department of Chemistry GDC Kulgam University of Kashmir
Keywords: oral carcinoma, Northern India, betel quid chewers, Cyclin D1,

Abstract


Cyclin D1 expression was positive in 35 cases of oral cancer with a Cyclin D1 positivity of 22.16±22.18. The percentage of positive cases as well as Cyclin D1 positivity showed an increase as the grade of differentiation advanced. No significant association was found between Cyclin D1 positivity and degree of differentiation of tumors (p=0.138). A significant difference in Cyclin D1 positivity was observed (p=0.043) comparing well differentiated (16.61+17.89) and poorly differentiated (37.0±32.51) tumors, as well as between well differentiated (16.61+17.89) and moderately differentiate tumors (24.38+21.93; p=0.002). Similarly, significant difference in Cyclin D1 positivity was observed comparing moderately differentiated (24.38+21.93) and poorly differentiated tumors (37.0±32.51; p =0.043). Cyclin D1 expression was more frequently seen in hard palate (75%), buccal mucosa (67 %) and lip (60 %) while expression of Cyclin D1 was less frequent in sites like gingiva (0 %), tongue (40 %) and floor of mouth (43 %). There was no association between Cyclin D1 expression and primary site of oral cancer (p=0.528) in tobacco and betel quid chewers of northern India.

Author Biography

Ayaz Mahmood Dar, Department of Chemistry GDC Kulgam University of Kashmir
Department of Chemistry GDC Kulgam University of Kashmir

References

Rivera C. Essentials of Oral Cancer. Int J Clin Exp Pathol. (2015); 8(9): 11884-11894

Curado MP, Edwards B, Shin HR, Ferlay J, Heanue M, et al. (eds). Cancer incidence in five continents: Vol. 9, IARC Scientific Publication No. 160. Lyon, France: International Agency for Research on Cancer, 2009. Available at http://www.iarc.fr/en/publications/pdfs -online/epi/sp160/CI5vol9.pdf

Coelho KR. Challenges of the Oral Cancer Burden in India. J Cancer Epidemiol. (2012): 701932

Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet (1993) 9(4): 138-41.

Sankaranarayanan R, Duffy SW, Day NE, Nair MK, Padmakumary G, A case- control investigation of cancer of the oral tongue and the floor of the mouth in southern India. International Journal of Cancer (1989) 44(4): 617-21.

Kumar M, Nanavati R, Modi TG, Dobariya C. Oral cancer: Etiology and risk factors: A review. J Can Res Ther 2016; 12: 458-63

Williams HK. Molecular pathogenesis of oral squamous carcinoma. Mol Pathol (2000)(4): 165-72.

Jurel SK, Gupta DS, Singh RD, Singh M, Srivastava S. Genes and oral cancer. Indian J Hum Genet. 2014 Jan; 20(1):4-9

Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? Journal of Pathology (1994) 172(1): 1-4.

Chiang CP, Lang MJ, Liu BY, Wang JT, Leu JS, Hahn LJ, Kuo MY. Expression of p53 protein in oral submucous fibrosis, oral epithelial hyperkeratosis, and oral epithelial dysplasia. Journal of Formos Medical Association (2000) 99(3): 229-34.

Hunter T, Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell (1994) 79(4): 573-82.

Jadhav KB, Gupta N. Clinicopathological Prognostic Implicators of Oral Squamous Cell Carcinoma: Need to Understand and Revise. N Am J Med Sci. 2013 Dec; 5(12):671-9.

Kudo Y, Takata T, Ogawa I, Kaneda T, Sato S, Takekoshi T, Zhao M, Miyauchi M, Nikai H. p27Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells. Clinical Cancer Research 2000; 6(3): 916-23.

Kuo MY, Lin CY, Hahn LJ, Cheng SJ, Chiang CP. Expression of cyclin D1 is correlated with poor prognosis in patients with areca quid chewing-related oral squamous cell carcinomas in Taiwan. Journal of Oral Pathological Medicine (1999) 28(4): 165-169.

Xu J, Gimenez-Conti IB, Cunningham JE, Collet AM, Luna MA, Lanfranchi HE, Spitz MR, Conti CJ. Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use: Cancer (1998) 83(2): 204-212.

Lam KY, Ng 1OL, Yuen APW, Kwong DLW, Wei W. Cyclin D1 expression in oral squamous cell carcinomas: clinicopathological relevance and correlation with p53 expression. Journal of Oral Pathological Medicine (2000) 29(4): 167-72.

Arora S., N. Chakravarti, M. Mathur, N.K. Shukla and R. Ralhan Expressions of PTEN and FHIT in oral squamous cell carcinoma and their relations with cyclinD1 modulators in oral cancer and cooreleation with tumor progression. Proceedings of the 2004 Miami Nature Biotechnology Winter Symposium Vol. 15

Staibano S, Mignogna MD, Lo Muzio L, Di Alberti L, Di Natale E, Lucariello A, Mezza E, Bucci E, DeRosa G. Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity. Human Pathology (1998) 11: 1189-1194

Gimenez-Conti IB, Collet AM, Lanfranchi H, Itoiz ME, Luna M, Xu HJ, Hu SX, Benedict WF, Conti CJ. p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas: Cancer (1996) 78(1):17-23

Angadi PV, Krishnapillai R. Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: correlation with histological differentiation: Oral Surg Oral Med Oral Pathology Oral Radiology Endod. (2007) 103(3): 30-35.

Takes RP, Baatenburg. RJ, Schuuring E, Latvinov SV, Van Kreiken JH. Differences in expression of oncogenes and suppressor genes in different sites of head and neck squamous carcinoma. Anticancer Research (1998) 18: 4793-800

Akervall JA, Michalides RJ, Mineta H, Balm A, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F, Wennerberg JP. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer (1997) 79(2):380-389.

Carlos de Vicente J, Herrero-Zapatero A, Fresno MF, López-Arranz JS. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance. Oral Oncology (2002) 38(3):301-308.

Wu M, Putti TC, Bhuiya TA. Comparative study in the expression of p53, EGFR, TGF-alpha, and cyclin D1 in verrucous carcinoma, verrucous hyperplasia, and squamous cell carcinoma of head and neck region. Appl. Immunohistochem. Mol. Morphol. (2002) 10(4): 351-356.

Neves Ada C, Mesquita RA, Novelli MD, Toddai E, De Sousa So Comparison between immunohistochemical expression of cyclin D1 and p21 and histological malignancy graduation of oral squamous cell carcinomas. Braz Dent J. (2004) 15(2):93-98.

Lam KY, Ng 1OL, Yuen APW, Kwong DLW, Wei W. Cyclin D1 expression in oral squamous cell carcinomas: clinicopathological relevance and correlation with p53 expression. Journal of Oral Pathological Medicine (2000) 29(4): 167-72.

Published
2018/06/18
Section
Original Scientific Paper